Showing Results from 1 to 12 of 13.
06 : 30 PM
Age, Race, and Insurance Status Influences on Anticoagulation Therapy and Discharge Disposition: A Retrospective Analysis
Tran Vi, Tjionas Panayiotis, Bowry Ritvij, Samuel Sophie
Final Pr. ID: TMP43
Authors: Tran Vi , Tjionas Panayiotis , Bowry Ritvij , Samuel Sophie
Keywords: Antithrombotic therapy, Apixaban, Atrial fibrillation, Warfarin, Stroke
07 : 00 PM
Apixaban for Preventing Recurrence of Ischemic Stroke in Patients with Atrial Cardiopathy: A Systematic Review and Meta-Analysis
Menegat Ana Luiza Rocha Soares, Menegaz De Almeida Artur, Kelly Francinny, A De Moraes Francisco Cezar, Menegat Brenda Luana Rocha Soares, Rachas Reis Mariana, Rocha Dantas Clara, De Souza Wagner Pedro, Matheus Gustavo Tadeu, Simões Bárbara, Alves Mylena, Bezerra Ian
Final Pr. ID: TP12
Authors: Menegat Ana Luiza Rocha Soares , Menegaz De Almeida Artur , Kelly Francinny , A De Moraes Francisco Cezar , Menegat Brenda Luana Rocha Soares , Rachas Reis Mariana , Rocha Dantas Clara , De Souza Wagner Pedro , Matheus Gustavo Tadeu , Simões Bárbara , Alves Mylena , Bezerra Ian
Keywords: Apixaban, Atrial fibrillation, Ischemic stroke, Factor Xa
07 : 00 PM
Characterization of Acute Ischemic Stroke (AIS) patients excluded from thrombolysis due to recent NOAC use.
Mok Kent, Palmisano Caitlin, Mcardle Patrick, Mehndiratta Prachi, Chaturvedi Seemant
Final Pr. ID: TP4
Authors: Mok Kent , Palmisano Caitlin , Mcardle Patrick , Mehndiratta Prachi , Chaturvedi Seemant
Keywords: Anticoagulants, Anticoagulation, Thrombolysis, Apixaban, Rivaroxaban
07 : 00 PM
Effectiveness and safety of apixaban vs. aspirin for primary prevention of stroke and bleeding risk among patients with atrial fibrillation: A Meta-analysis of randomized controlled trials including ARTESIA trial.
Jaiswal Vikash, Ang Song Peng, Younas Ayesha, Hanif Muhammad, Biswas Monodeep, Savaliya Mittal, Shama Nishat, Jaiswal Akash, Munnangi Pragathi, Mashkoor Yusra, Zulfiqar Aayet, Rajak Kripa, Halder Anupam
Final Pr. ID: WP282
Authors: Jaiswal Vikash , Ang Song Peng , Younas Ayesha , Hanif Muhammad , Biswas Monodeep , Savaliya Mittal , Shama Nishat , Jaiswal Akash , Munnangi Pragathi , Mashkoor Yusra , Zulfiqar Aayet , Rajak Kripa , Halder Anupam
Keywords: Apixaban, Atrial fibrillation, Aspirin, Stroke, Safety
07 : 00 PM
Efficacy and Safety of Apixaban for Stroke Prevention in Atrial Fibrillation: A Study-Level Meta-Analysis of Randomized Controlled Trials
Sebastian Sneha Annie, Varghese Varna, Padda Inderbir
Final Pr. ID: TP23
Authors: Sebastian Sneha Annie , Varghese Varna , Padda Inderbir
Keywords: Apixaban, Stroke, Atrial fibrillation, Anticoagulants, Efficacy
10 : 30 AM
Efficacy and Safety of Direct-Acting Oral Anticoagulants Compared to Vitamin K Antagonists for Atrial Fibrillation in Patients with Liver Cirrhosis: A Meta-Analysis
Ramos Miranda Maria Clara, Santos Charles Karel, Barbosa Gabriel, Nogueira Thallys, Da Silva Menezes Junior Antonio
Final Pr. ID: Sa2082
Authors: Ramos Miranda Maria Clara , Santos Charles Karel , Barbosa Gabriel , Nogueira Thallys , Da Silva Menezes Junior Antonio
Keywords: Atrial fibrillation, Direct factor Xa inhibitor, Warfarin, Apixaban, Rivaroxaban
09 : 30 AM
Gastrointestinal Bleeding Risk: Diltiazem versus Metoprolol in Patients on Rivaroxaban, Apixaban, or Dabigatran.
Seylani Allen, Haile Yohannes, Asiedu Samuel, Shahin Hania
Final Pr. ID: MDP1380
Authors: Seylani Allen , Haile Yohannes , Asiedu Samuel , Shahin Hania
Keywords: Arrhythmias, treatment of, Dabigatran, Apixaban, Rivaroxaban, Drugs
02 : 24 PM
Genomic Profiling and Risk of Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Apixaban
Clocchiatti-tuozzo Santiago, Gill Thomas, Falcone Guido, Rivier Cyprien, Huo Shufan, Gilmore Emily, Shoamanesh Ashkan, Kamel Hooman, Murthy Santosh, Ohno-machado Lucila, Sheth Kevin
Final Pr. ID: 49
Authors: Clocchiatti-tuozzo Santiago , Gill Thomas , Falcone Guido , Rivier Cyprien , Huo Shufan , Gilmore Emily , Shoamanesh Ashkan , Kamel Hooman , Murthy Santosh , Ohno-machado Lucila , Sheth Kevin
Keywords: Genomics, Intracranial hemorrhage, Apixaban, Atrial fibrillation, Personalized Medicine
07 : 42 AM
Infarct Topography, Effect of Anticoagulation, and Recurrence after Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Karunamuni Nilushi, Gologorsky Rachel, Longstreth W, Tirschwell David, Elkind Mitchell, Kamel Hooman
Final Pr. ID: 136
Authors: Karunamuni Nilushi , Gologorsky Rachel , Longstreth W , Tirschwell David , Elkind Mitchell , Kamel Hooman
Keywords: Cardioembolic stroke, Stroke, Apixaban, Prevention, Atrial function
09 : 51 AM
New Oral Anticoagulant Therapy Versus Warfarin In Patients With Atrial Fibrillation And Previous Stroke or Transient Ischemic Attack. An Updated Meta-analysis.
Obi Ogechukwu, Cavalcante Deivyd, Nweze Uchenna, Asonye Patricia, Lee Timothy
Final Pr. ID: 145
Authors: Obi Ogechukwu , Cavalcante Deivyd , Nweze Uchenna , Asonye Patricia , Lee Timothy
Keywords: Stroke, Cerebrovascular disorders, Warfarin, Apixaban, Dabigatran
10 : 30 AM
Pharmacosurveillance study of FDA Adverse Event Reporting System (FAERS) events of Apixaban and Rivaroxaban
Logvinsky Ilana, Maddineni Gautam, Wood Malissa, Delibasic Maja
Final Pr. ID: Sa2079
Authors: Logvinsky Ilana , Maddineni Gautam , Wood Malissa , Delibasic Maja
Keywords: Anticoagulants, Apixaban, Arrhythmias, treatment of, Rivaroxaban, Hemorrhage
Shah Sachin, Dinger Tai, Blacker Deborah, Greenberg Steven, Newhouse Joseph, Lykken Jacquelyn, Pandya Ankur, Hsu John, Hyle Emily
Final Pr. ID: WP217
Authors: Shah Sachin , Dinger Tai , Blacker Deborah , Greenberg Steven , Newhouse Joseph , Lykken Jacquelyn , Pandya Ankur , Hsu John , Hyle Emily
Keywords: Anticoagulants, Apixaban, Aging, Intracranial hemorrhage, Drug interactions